Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07246863 |
| Title | Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | CatalYm GmbH |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) | NOT_YET_RECRUITING | Birmingham | Alabama | 35294-3300 | United States | Details |
| Duke University Medical Center | NOT_YET_RECRUITING | Durham | North Carolina | 27710 | United States | Details |
| University Hospital of Jaen | RECRUITING | Jaén | Andalusia | 23007 | Spain | Details |
| University Hospital Basel | RECRUITING | Basel | 4031 | Switzerland | Details | |
| Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology | RECRUITING | Sankt Gallen | CH-9007 | Switzerland | Details |